Promising early results from Parkinson’s ... - Cure Parkinson's

Cure Parkinson's

25,550 members26,870 posts

Promising early results from Parkinson’s vaccine study

CuriousMe12 profile image
5 Replies

A study in people with Parkinson’s has found that a vaccine can help slow down clumping of a protein known to be linked to the conditionparkinsons.org.uk/news/prom...

Written by
CuriousMe12 profile image
CuriousMe12
To view profiles and participate in discussions please or .
5 Replies
park_bear profile image
park_bear

Currently recruiting for Phase 2 study of this vaccine. Eligibility criteria are reasonably broad but takes place in New York City only so far. Lumbar puncture will be part of the study procedure:

clinicaltrials.gov/study/NC...

vaxxinity.com/our-pipeline/

UB-312 (α-synuclein)

"Targets toxic forms of aggregated α-synuclein in the brain to fight Parkinson’s and other synucleinopathies, such as dementia with Lewy Body (“DLB”) and multiple system atrophy (“MSA”). The first part of a Phase 1 trial in healthy volunteers has shown UB-312 to be well tolerated, with no significant safety findings, and immunogenic, with a high responder rate and antibodies that cross the blood-brain barrier"

Phase 1 results: movementdisorders.onlinelib...

"Twenty-three participants received all three vaccinations of UB-312. Most adverse events were mild, transient, and self-resolving. Common treatment-emergent adverse events included headache, nasopharyngitis, vaccination-site pain, lumbar puncture-site pain, and fatigue. UB-312 induced dose- and time-dependent antibody production. Antibodies were detectable in serum and CSF of all participants receiving the 300/300/300 μg UB-312 dose regimen. The average CSF/serum ratio was 0.2%"

Animal test:

ncbi.nlm.nih.gov/pmc/articl...

They used genetically modified mice that actually develop human-like Parkinson's. With that said they did apply the vaccine relatively early in the mouse development, before gross Parkinson's symptoms appeared. So that does leave uncertainty as to how well this would work in a more developed case of Parkinson's.

robinson621 profile image
robinson621

sounds hopeful

Likii profile image
Likii

Hilarious. Another half-baked gene therapy to force the body to deal with manmade intoxicants.

Trust The Science!

Humans will never learn.

kaypeeoh profile image
kaypeeoh

But, but, but...alpha syn hasn't been proven to be a cause and not an effect?

CuriousMe12 profile image
CuriousMe12 in reply to kaypeeoh

I believe it's definitely seen as part of the problem. How close to the root problem it is,I'm not sure if anyone definitely knows.

You may also like...

Parkinson’s and vagal nerve stimulation, promising human studies.

therapy. No difference was found in the Unified Parkinson's Disease Rating Scale III, Timed...

The Latest in Efforts to Develop a Vaccine against Parkinson’s

this email from the Michael J. Fox Foundation \\"A vaccine to slow or stop...

Pioneering stem-cell trials in Japan report promising early results

trial expected to report results soon, in which researchers used donor-derived iPS cells to...

Compounds in Chinese Herbal Medicine May Treat Parkinson’s, Study Suggests

that may be of therapeutic value in Parkinson’s disease, researchers suggest....

Parkinson’s breakthrough as ‘valuable’ study pinpoints brain cells linked to disease

co.uk/news/science/1606855/parkinson-s-disease-breakthrough-brain-cells-dopamine-study-research-mit-